CentraState becomes 109th Site in Region DENVER, June 17 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an international e-Health, medical information technology company, today announced that its Wyndgate Technologies(R) division has licensed its SafeTrace Tx(R) transfusion management software to CentraState Healthcare System ("CentraState") of Freehold, New Jersey. Terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Cynthia Kasten, CLS, MT, BS, Laboratory Manager/Blood Bank Supervisor for CentraState Medical Center stated, "We noticed Wyndgate's products in a professional journal and decided to research their transfusion system for our blood bank. After applying the American Association of Blood Bank's ("AABB") Quality System Essentials point system to assess various software systems, we found that Wyndgate's SafeTrace Tx software met our hospital's criteria." Ms. Kasten continued, "The Patient-At-A-Glance(R) bar was a major eye-catching feature which will allow us to view critical data at each step in the process. With SafeTrace Tx, we expect to enhance the level of patient safety through the extensive array of test safety checks and make our process more efficient." SafeTrace Tx is a blood management software system designed to raise the standard of care for patients, improve safety, reduce waste and increase efficiency. SafeTrace Tx provides comprehensive tracking of orders, specimens, blood products, derivatives, and accessories with a complete testing and transfusion history in one consolidated record. These complex features will assist CentraState in improving their processes, making it easier for their technicians to provide appropriate blood products for their patients. Wm. Scott Dustin, Vice President of Sales and Marketing at Wyndgate Technologies, commented, "We are excited to have been chosen to assist CentraState with enhancing patient safety in their hospital. Working with CentraState staff during the contracting process has been a pleasure. We are looking forward to supporting CentraState with quality products and services as they continue to provide excellent, advanced healthcare to patients in their community." About CentraState Healthcare System CentraState Healthcare System is a private, not-for-profit health organization with an acute-care medical center licensed for 271 beds, a new 171,000-square-foot outpatient center and three senior living communities. In 2005 CentraState Medical Center became affiliated with the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School as a teaching hospital. In the same year the hospital was awarded Magnet designation for nursing excellence by The American Nurses Credentialing Center (ANCC) of the American Nursing Association. About Global Med Technologies, Inc. Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada, Africa, and the Caribbean. Wyndgate's software provides Vein-to-Vein(R) tracking from donor collection to patient transfusion through its Donor Doc(TM) interactive donor health history questionnaire, ElDorado Donor(TM) and SafeTrace(R) donor management systems, to its SafeTrace Tx(R) advanced transfusion management system. Global Med's PeopleMed(R), Inc. subsidiary provides custom software validation, consulting and compliance solutions to hospitals and blood centers. PeopleMed's in-depth knowledge of Wyndgate's products and the blood banking industry results in cost-effective validation services, which leads to more efficient software implementations and upgrades for our customers. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R), Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000, ; Investors, Paul Holm, President of portfoliopr.inc, +1-212-888-4570, , for Global Med Technologies, Inc. Web site: http://www.globalmedtech.com/

Copyright